Antiapoptotic Bcl-2 family protein expression: Increases with progression of oligodendroglioma

Cancer

Volumn 86, Issue 9, 1999, Pages 1832-1839

  Deininger, Martin H ^a   Weller, Michael ^a   Streffer, Johannes ^a   Meyermann, Richard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl X; In situ nick translation; Ki 67; Mcl 1; Oligodendroglioma; Progression

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0033230359     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1832::AID-CNCR27>3.0.CO;2-A     Document Type: Article

References (32)

1. Mork SJ, Halvorsen TB, Lindegaard KF, Eide GE. Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 1986;45:65-78.
2. Hagel C, Laking G, Laas R, Scheil S, Jung R, Milde-Langosch K, et al. Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas. Eur J Cancer 1996;32A: 2242-8.
3. Morelli S, Delia D, Capaccioli S, Quattrone A, Schiavone N, Bevilacqua A, et al. The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides. Proc Natl Acad Sci USA 1997;94:8150-5.
4. Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R. Bcl-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 1998;155:68-75.
5. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-3.
6. Ottilie S, Diaz JL, Chang J, Wilson G, Tuffo KM, Weeks S, et al. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation. J Biol Chem 1997;272: 16955-61.
7. L. Mol Cell Biol 1997;17:7040-6.
8. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997;386:728-31.
9. Naumovski L, Cleary ML. The p53-binding protein 53BP2 also interacts with Bcl2 and impedes cell cycle progression at G2/M. Mol Cell Biol 1996;16:3884-92.
10. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994;9:2751-6.
11. Sabbatini P, Chiou SK, Rao L, White E. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol 1995;15:1060-70.
12. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, et al. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 1998;58: 3116-31.
13. L, an inhibitor of programmed cell death. Nature 1996;381: 335-41.
14. Schendel SL, Xie Z, Montal MO, Matsuyama S, Montai M, Reed JC. Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997;94:5113-8.
15. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68.
16. Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, et al. Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer 1998;79:640-4.
17. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wekerle H, et al. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 1993;41: 1023-30.
18. Reed JC. Regulation of apoptosis by Bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995;7:541-6.
19. Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC. Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 1997;94:369-75.
20. Milner AE, Grand RJ, Vaughan AT, Armitage RJ, Gregory CD. Differential effects of Bcl-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation. Oncogene 1997;15:1815-22.
21. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 1994;35:1018-34.
22. Bello MJ, Leone PE, Vaquera J, de Campos JM, Kusak ME, Sarasa JL, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 1995;64:207-10.
23. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-9.
24. Reifenberger J, Reifenberger G, Ichimura K, Schmidt EE, Wechsler W, Collins VP. Epidermal growth factor receptor expression in oligodendroglial tumors. Am J Pathol 1996; 149:29-35.
25. Pavelic J, Hlavka V, Poljak M, Gale N, Pavelic K. p53 immunoreactivity in oligodendrogliomas. J Neurooncol 1994;22: 1-6.
26. Kros JM, Hop WC, Godschalk JJ, Krishnadath KK. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 1996;78:1107-13.
27. Di Rocco F, Carroll RS, Zhang J, Black PM. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 1998;42:341-6.
28. Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJ, Cavenee WK, et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol Berlin 1997;93:109-17.
29. Schiffer D, Dutto A, Cavalla P, Chio A, Migheli A, Piva R. Role of apoptosis in the prognosis of oligodendrogliomas. Neurochem Int 1997;31:245-50.
30. Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 1997;41:878-84.
31. Kros JM, Godschalk JJ, Krishnadath KK, Van-Eden CG. Expression of p53 in oligodendrogliomas. J Pathol 1993;171: 285-90.
32. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.